GDAP1 and Charcot-Marie-Tooth disease: Evaluation in children and adolescents may be key to highlight the role of modifier genes (e.g., JPH1 as a modifier of GDAP1‐associated CMT), since at their young age they have not been exposed to external factors like medical co‐morbidities, drugs or other toxins.